|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| C07D 239/42 | (2013.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61K 31/505 | (2013.01) | ||
| A61K 47/00 | (2006.01) | ||
| A61K 31/517 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 31/5377 | (2006.01) | ||
| C07D 239/42 | (2006.01) |
| (11) | Number of the document | 3054952 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14851657.8 |
| Date of filing the European patent application | 2014-10-06 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/059238 |
| Date | 2014-10-06 |
| (87) | Number | WO 2015/054099 |
| Date | 2015-04-16 |
| (30) | Number | Date | Country code |
| 201361888207 P | 2013-10-08 | US |
| (72) |
TAMANG, David Lee , US
YANG, Min , US
JONES, Simon S. , US
|
| (73) |
Acetylon Pharmaceuticals, Inc. ,
70 Fargo Street, Suite 205, Boston, MA 02210,
US
|
| (54) | COMBINATIONS OF HISTONE DEACETYLASE 6 INHIBITORS AND THE HER2 INHIBITOR LAPATINIB FOR USE IN THE TREATMENT OF BREAST CANCER |
| COMBINATIONS OF HISTONE DEACETYLASE 6 INHIBITORS AND THE HER2 INHIBITOR LAPATINIB FOR USE IN THE TREATMENT OF BREAST CANCER |